The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

BTK inhibitors

BTK inhibitors

Bruton Tyrosine Kinase (BTK) inhibitors inhibit the enzyme BTK, which plays a crucial role in oncogenic signaling and interactions with tumor microenvironment critical for proliferation, and survival of malignant B cells. Examples of BTK inhibitors include ibrutinib, zanubrutinib, and acalabrutinib.

|||